By Karlee Weinmann ( December 17, 2013, 1:10 PM EST) -- Spanish drugmaker Almirall SA said Tuesday it would pay roughly $400 million for private equity-backed prescription skin-care company Aqua Pharmaceuticals LLC, a move that will diversify its holdings and allow it to crack into the biggest dermatology market in the world....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.